Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDE1A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | NKAIN2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | NNT | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | FAM13C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | RAB3A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | DDX27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | NARS | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | METTL24 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SCG3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |